Please wait a minute...
文章检索
预防医学  2026, Vol. 38 Issue (5): 536-540    DOI: 10.19485/j.cnki.issn2096-5087.2026.05.023
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2015—2024年桐乡市结直肠癌发病和死亡趋势分析
曹元, 沈钲杰, 谢开婿
桐乡市疾病预防控制中心,浙江 桐乡 314500
Trends in incidence and mortality of colorectal cancer in Tongxiang City from 2015 to 2024
CAO Yuan, SHEN Zhengjie, XIE Kaixu
Tongxiang Center for Disease Control and Prevention, Tongxiang, Zhejiang 314500, China
全文: PDF(843 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2015—2024年浙江省桐乡市结直肠癌发病和死亡趋势,为优化区域结直肠癌防控策略提供依据。方法 通过浙江省慢性病监测信息管理系统收集2015—2024年桐乡市结直肠癌发病和死亡资料,计算结直肠癌粗发病率、粗死亡率,采用2000年第五次全国人口普查标准人口年龄构成计算标化率。采用平均年度变化百分比(AAPC)分析发病率和死亡率变化趋势。结果 2015—2024年桐乡市结直肠癌年均粗发病率为47.89/10万,粗发病率呈上升趋势(AAPC=5.845%,P<0.05);年均标化发病率为22.14/10万,标化发病率趋势无统计学意义(P>0.05)。男性结直肠癌年均粗发病率、年均标化发病率高于女性(均P<0.05);男性粗发病率、标化发病率呈上升趋势(AAPC=4.920%、2.799%,均P<0.05),女性粗发病率、标化发病率趋势无统计学意义(均P>0.05)。≥75岁组结直肠癌年均粗发病率较高,为173.37/10万;50~<65岁组粗发病率呈上升趋势(AAPC=3.970%,P<0.05),其他年龄组粗发病率趋势无统计学意义(均P>0.05)。2015—2024年桐乡市结直肠癌年均粗死亡率、年均标化死亡率分别为18.74/10万、7.58/10万;粗死亡率、标化死亡率趋势无统计学意义(均P>0.05)。男性结直肠癌年均粗死亡率、年均标化死亡率高于女性(均P<0.05);男性、女性粗死亡率、标化死亡率趋势无统计学意义(均P>0.05)。≥75岁组结直肠癌年均粗死亡率较高,为131.73/10万;各年龄组粗死亡率趋势无统计学意义(均P>0.05)。结论 2015—2024年桐乡市结直肠癌发病率呈上升趋势,死亡率变化平缓;男性、中老年人群是结直肠癌防控重点人群。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
曹元
沈钲杰
谢开婿
关键词 结直肠癌发病率死亡率平均年度变化百分比    
AbstractObjective To analyze the incidence and mortality trends of colorectal cancer in Tongxiang City, Zhejiang Province from 2015 to 2024, so as to provide the evidence for optimizing regional colorectal cancer prevention and control strategies. Methods Data on colorectal cancer incidence and mortality in Tongxiang City from 2015 to 2024 were collected through the Zhejiang Provincial Chronic Disease Surveillance Information Management System. The crude incidence and crude mortality of colorectal cancer were calculated, and age-standardized rates were derived using the standard age structure from the Fifth National Population Census in 2000. The trends in incidence and mortality were analysed using the average annual percent change (AAPC). Results From 2015 to 2024, the annual crude incidence of colorectal cancer in Tongxiang City was 47.89/105, showing an upward trend (AAPC=5.845%, P<0.05); the annual age-standardized incidence was 22.14/105, with no statistically significant trend (P>0.05). From 2015 to 2024, the annual crude incidence and annual age-standardized incidence of colorectal cancer among men in Tongxiang City were higher than those among women (both P<0.05). The crude incidence and age-standardized incidence for men showed upward trends (AAPC=4.920%, 2.799%, both P<0.05), while the trends in crude incidence and age-standardized incidence for women were not statistically significant (both P>0.05). The annual crude incidence of colorectal cancer in the ≥75 age group was relatively high at 173.37/105; The crude incidence in the 50-<65 age group showed an upward trend (AAPC=3.970%, P<0.05), while trends in crude incidence for other age groups were not statistically significant (all P>0.05). From 2015 to 2024, the annual crude mortality and annual age-standardized mortality of colorectal cancer in Tongxiang City were 18.74/105 and 7.58/105, respectively; trends in crude mortality and age-standardized mortality were not statistically significant (both P>0.05). The annual crude mortality and annual age-standardized mortality of colorectal cancer were higher in men than in women (both P<0.05); there were no statistically significant trends in crude mortality and annual age-standardized mortality for either men or women (all P>0.05). The annual crude mortality of colorectal cancer was higher in the ≥75 age group, at 131.73/105; there were no statistically significant trends in crude mortality across age groups (all P>0.05). Conclusions From 2015 to 2024, the incidence of colorectal cancer in Tongxiang City showed an upward trend, while the mortality remained relatively stable. Men and the middle-aged and elderly were the key target groups for the prevention and control of colorectal cancer.
Key wordscolorectal cancer    incidence    mortality    average annual percent change
收稿日期: 2026-01-09      修回日期: 2026-05-09     
中图分类号:  R735.3  
作者简介: 曹元,本科,主管医师,主要从事慢性病防治工作,E-mail:827726127@qq.com
引用本文:   
曹元, 沈钲杰, 谢开婿. 2015—2024年桐乡市结直肠癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(5): 536-540.
CAO Yuan, SHEN Zhengjie, XIE Kaixu. Trends in incidence and mortality of colorectal cancer in Tongxiang City from 2015 to 2024. Preventive Medicine, 2026, 38(5): 536-540.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2026.05.023      或      https://www.zjyfyxzz.com/CN/Y2026/V38/I5/536
[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263.
[2] 中华人民共和国国家卫生健康委员会医政司,中华医学会肿瘤学分会.国家卫生健康委员会中国结直肠癌诊疗规范(2025版)(精简版)[J].中国实用外科杂志,2025,45(12):1353-1359.
[3] CAO W,CHEN H D,YU Y W,et al.Changing profiles of cancer burden worldwide and in China:a secondary analysis of the global cancer statistics 2020[J].Chin Med J,2021,134(7):783-791.
[4] 程向东,杜灵彬.2023浙江省肿瘤登记年报[M].北京:清华大学出版社,2024.
[5] 朱陈,龚巍巍,钟节鸣,等.浙江省重点人群结直肠癌筛查项目设计和实施方案[J].中国肿瘤,2020,29(12):899-903.
[6] 赫捷.2022中国肿瘤登记年报[M].北京:人民卫生出版社,2025.
[7] 朱云峰,高田静,陆恩宁,等.2007—2018年浙江省海宁市结直肠癌发病与死亡趋势分析[J].中国肿瘤,2024,33(4):269-276.
[8] 崔俊鹏,陆艳,王临池,等.2007—2016年江苏省苏州市居民恶性肿瘤发病及生存分析[J].中国肿瘤,2023,32(6):470-474.
[9] 夏昌发,陈万青.中国恶性肿瘤负担归因于人口老龄化的比例及趋势分析.中华肿瘤杂志,2022,44(1):79-85.
[10] 李玉荣,王冬飞,高媛媛,等.2010—2024年萧山区结直肠癌发病趋势分析[J].预防医学,2025,37(9):927-931,936.
[11] SUR D K C,BROWN P C.Colorectal cancer screening and prevention[J].Am Fam Physician,2025,112(3):278-283.
[12] 亓爱玲,窦磊然,杨梦诗,等.2013—2022年山东省济南市结直肠癌发病与死亡分析及2023—2030年变化趋势预测[J].中国肿瘤,2025,34(12):931-937.
[13] 陈铭睿,林玲,楚楚,等.2013—2022年南通市结直肠癌发病和死亡趋势分析[J].预防医学,2025,37(10):1039-1044.
[14] WELE P,WU X,SHI H F.Sex-dependent differences in colorectal cancer:with a focus on obesity[J/OL].Cells,2022,11(22)[2026-05-09].http://doi.org/10.3390/cells11223688.
[15] 甄林青,许正国,李超,等.浙江省临海市2020—2021年重点人群结直肠癌筛查结果分析[J].肿瘤,2023,43(1):42-52.
[16] 程向东,杜灵彬.2024浙江省肿瘤登记年报[M].北京:清华大学出版社,2025.
[17] 陈章涵,甘思琪,曹艺源,等.全球早发性结直肠癌疾病负担及趋势分析[J].中国临床医学,2025,32(5):734-742.
[18] 周凡,王小红,陈梦倩,等.2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J].预防医学,2026,38(1):26-30.
[1] 姜雪霞, 叶振淼, 樊丽辉, 郑宇航, 罗永园, 李慧君, 夏喆铮. 2015—2022年温州市女性乳腺癌发病趋势分析[J]. 预防医学, 2026, 38(5): 478-482.
[2] 李景琦, 李晨曦, 董立平. 1994—2023年中国脑卒中发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2026, 38(5): 488-492,497.
[3] 冯豪, 李广辉, 田阳阳, 葛锐. 2015—2024年嘉兴市生殖道沙眼衣原体感染流行特征及趋势分析[J]. 预防医学, 2026, 38(5): 493-497.
[4] 韦艳炼, 农圣, 漆光紫, 江建明. 1990—2023年中国肝癌疾病负担变化趋势及年龄-时期-队列分析[J]. 预防医学, 2026, 38(5): 473-477.
[5] 张爱平, 袁芳, 蔡一飙, 岑焕新, 潘劲. 2014—2023年江北区冠心病死亡特征及趋势分析[J]. 预防医学, 2026, 38(5): 504-507,512.
[6] 徐露婷, 田雨涵, 蒲焱. 贵阳市恶性肿瘤疾病负担分析[J]. 预防医学, 2026, 38(5): 517-522.
[7] 金茜, 叶振淼, 姜雪霞, 樊丽辉, 张默涵, 谢轶敏, 罗永园, 郑宇航. 2016—2023年温州市糖尿病发病趋势分析[J]. 预防医学, 2026, 38(4): 372-376.
[8] 杨慧, 张以祥, 赵梅玲. 2006—2024年洪泽区HIV/AIDS病例特征分析[J]. 预防医学, 2026, 38(4): 402-405.
[9] 李海华, 叶勇, 袁瑞, 运靖宜, 王浩博, 傅雨欣. 2006—2025年湖州市儿童青少年糖尿病发病趋势及年龄-时期-队列分析[J]. 预防医学, 2026, 38(3): 257-262.
[10] 闫瑞平, 李建彬, 安戈, 郭向娇, 黄婼璇, 宋彩娟. 2016—2021年郑州市肿瘤登记地区甲状腺癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(3): 267-273.
[11] 朱凯强, 唐慧玲, 陈依娜, 李卫丹, 张子根. 2015—2024年金华市肺结核流行特征分析[J]. 预防医学, 2026, 38(3): 237-241.
[12] 仲玮, 李伟伟, 相璐, 柴莉莉, 董建梅, 马昭君, 秦绪成, 张伟伟. 2011—2029年连云港市慢性呼吸系统疾病死亡趋势及预测研究[J]. 预防医学, 2026, 38(2): 181-186.
[13] 舒奇, 夏文霞, 李振娟, 朱晓云. 2003—2023年金山区居民伤害死亡与减寿趋势分析[J]. 预防医学, 2026, 38(2): 156-160,165.
[14] 韩亚蓉, 韩颖颖, 蔡波, 林玲. 2013—2022年南通市甲状腺癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(1): 20-25.
[15] 周凡, 王小红, 陈梦倩, 张小兰, 徐则林. 2016—2027年金华市结直肠癌发病和死亡趋势分析及预测[J]. 预防医学, 2026, 38(1): 26-30.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed